Globe Newswire

"DO IT TO ME" by DaniLeigh Joins Music Licensing, Inc. (OTC: SONG) Portfolio Jun 13, 2024 09:37AM

Naples, FL, June 13, 2024 (GLOBE NEWSWIRE) -- The royalty-generating intellectual property of "DO IT TO ME" by DaniLeigh has been acquired by Music Licensing, Inc. (OTC: SONG), a leading entity in the acquisition and management of music royalties. This strategic acquisition highlights the company's commitment to enriching its portfolio with high-quality assets.

Watch "DO IT TO ME" by DaniLeigh here.

About Music Licensing, Inc. (OTC: SONG) (... (continue reading...)

"DO IT TO ME" by DaniLeigh Joins Music Licensing, Inc. (OTC: SONG) Portfolio Jun 13, 2024 09:37AM

Naples, FL, June 13, 2024 (GLOBE NEWSWIRE) -- The royalty-generating intellectual property of "DO IT TO ME" by DaniLeigh has been acquired by Music Licensing, Inc. (OTC: SONG), a leading entity in the acquisition and management of music royalties. This strategic acquisition highlights the company's commitment to enriching its portfolio with high-quality assets.

Watch "DO IT TO ME" by DaniLeigh here.

About Music Licensing, Inc. (OTC: SONG) (... (continue reading...)

Results of Annual General Meeting Jun 13, 2024 09:35AM

13 June 2024

Biodexa Pharmaceuticals PLC

(“Biodexa” or the “Company”)

Results of Annual General Meeting

Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announces that at its Annual General Meeting held earlier today, all resolutions put to the Company’s shareholders were duly passed.

The full text of, inter... (continue reading...)

FibroBiologics Set to Join Russell 2000® Index Jun 13, 2024 09:31AM

HOUSTON, June 13, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced today it is set to join the Russell 2000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of... (continue reading...)

Form 8.3 - Keywords Studios Plc Jun 13, 2024 09:29AM

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be... (continue reading...)